is defined as the sum of all homocysteine species in plasma/serum, including free and proteinbound forms. In the present review, we compare and evaluate several techniques forthe determination of total homocystelne. Because these assays include the conversion of all forms into a single species by reduction, the redistribution between free and protein-bound homocysteine through disulfide interchange does not affect the results, and total homocysteine can be measured in stored samples. Total homocysteine in whole blood increases at room temperature because of a continuous production and release of homocysteine from blood cells, but artificial increase is low if the blood sample is centrifuged within 1 h of collection or placed on ice. Different methods correlate well, and values between 5 and 15 mol/L in fasting subjects are considered normal. Total homocysteine in serum/plasma is increased markedly in patients with cobalamin or folate deficiency, and decreases only when they are treated with the deficient vitamin. Total homocysteine is therefore of value for the diagnosis and follow-up of these deficiency states and may compensate for weaknesses of the traditional laboratory tests. In addition, total homocysteine is an independent risk factor for premature cardiovascular diseases. These disorders justify introduction of the total homocysteine assay in the routine clinical chemistry laboratory. abbreviations: ABD-F, 4-(aminosulfonyl)-7.fluoro-2,1,3.benzoxadiazole-4-su]fonate; GC-MS, gas chromatography-mass spectrometry; Hcy, homocysteine; mBrB, monobromobimane; and SBD-F, ammonium-7-fluoro-2,1,3-benzoxadiazole-4-sulfonate.
tine into the urine, and the blood concentrations become extremely high (3). The high concentrations could be determined by simple chemical tests (4) or by amino acid analysis.
Hey in the acid-soluble fraction of plasma/serum (free Hey) was detected in healthy subjects with the secondgeneration amino acid analyzers that became available in the middle 1970s (5, 6). The first clinical studies on the relation between moderately increased plasma Hey and increased risk for cardiovascular disease, published in the late 1970s and early 1980s, were based on this methodology (7-9).
Progress in Hcy research during the last 7 years has been greatly facilitated by the introduction of improved techniques for measuring Hey in plasma and serum (10-19). These methods measure total Hey, which is the sum of protein-bound and free Hey. Since 1985, the value of plasma/serum Hey determination in the diagnosis and follow-up of folate or cobalamin deficiencies has been established. These deficiency states are probably the most frequently encountered causes of marked increases of serum/plasma and y-cystathionase are Hey-catabolizing enzymes, for which Km values are >1 mmol/L. Cystathionine /3-synthase is activated by S-adenosylmethionine, and the concentrations of both enzymes increase in response to excess dietary methionine. These properties ensure both immediate and longterm drainage of excess Hey via the tranasulfuration pathway (31).
The Hey-remethylating enzymes, 5-methyltetrahydrofolate-Hey methyltransferase and betaine-Hey methyltransferase, have low Km values for Hey (<0.1 mmol/L). The activity is (directly or indirectly) inhibited by S-adenosylmethionine, and increased dietary methionine decreases the activity of the former enzyme. These properties favor methionine conservation at low Hey concentrations(31).
Hey export. The release of Hey into the extracellular medium represents the third route of cellular Hey disposal and is particularly important in relation to the plasma concentration of Hey. Studies with isolated cells show that Hey export into the extracellular medium reflects an imbalance between Hey production and me- tabolism (32, 33) . When cells are cultured in the presence of excess methionine, Hey export from most cell lines is enhanced (33) ; this phenomenon resembles the response to the methionine loading test. Pharmacological (34) and cell genetic studies (B. Christensen et al., unpublished) show that the activity of methionine synthase is critical for Hey export at low methionine concentrations, whereas cystathionine /3-synthase activity influences the export at high methionine concentrations. The clinical corollary is that methionine synthase activity determines the concentration of fasting plasma Hey, whereas a defect in cystathionine /3-synthase results in an abnormal response to methionine loading. This model is supported by clinical Cobalamin-deficient patients and one patient with methylenetetrahydrofolate reductase deficiency had normal increases in plasma Hey after methionine loading (37), whereas patients who were homozygotes (3, 38) or obligate heterozygotes (39, 40) for cystathionine /3-synthase deficiency showed an abnormal response.
Different Forms of Hcy In Human Plasma: Implications for Hcy Determination
In the first studies of plasma Hey in healthy subjects (5, 41) and in some early clinical studies (20) , Hey was measured in the acid-soluble fraction of plasma as Heycysteine mixed disulfide. However, a major fraction of Hey in serum/plasma is associated with plasma protein(s) (42), and probably forms a protein-Hey mixed disulfide with albumin (10). This fraction represents -70% of total Hey in human plasma/serum from healthy subjects (10). Only trace amounts of reduced Hey (11, 43, 44) and the disulfide homocystine (45) have been demonstrated. The sum of all Hey species in plasma (free plus protein-bound) is referred to as total Hey.
The protein binding of Hey in plasma has some unique features. Both experimental (46,47) and clinical studies (48) demonstrate the presence in plasma of binding sites for aminothiols, which interact preferentially with Hey. In contrast to cysteine, binding of Hey to plasma proteins seems to be saturable, with a maximal capacity of -140 imol/L (48). This implies that the free fraction of Hey increases more than protein-bound Hey does when total Hey is markedly increased. During the brief hyperhomocysteinemia induced by methionine loading, only a moderate, transient increase in the free/ bound ratio occurs. This indicates that a rapid equilibrium exists between free and protein-bound fractions in vivo (20) . (15) or heating (52) at lower concentrations (40-100 mmol/L). Formation of gas and foaming during the reaction may impose practical problems, especially with regard to automatization, but this can be overcome by adding a surface-active agent, e.g., octanol. Tri-n-butylphosphine does not react with thiol-specific reagents nor does it form gas during reaction; however, it consumes fluorogenic reagent (mBrB) both at 50#{176}C and at room temperature (53) and is an irritant with an unpleasant odor. Sample output depends on sample processing and chromatographic retention time. Manual processing of a large number of samples followed by a rapid chromatographic step gives a high sample output, as demonstrated for GC-MS (12) and for assays based on electrochemical detection (13) or fluorescence detection with use of SBD-F (18 Another drawback is the limited range of this assay, owing to the consumption of radioactive adenosine present in the assay mixture.
Gas Chromatography-Mass
Spectrometry
The GC-MS method for total Hey developed by Stabler et al. (12) has been modified recently (65) and is much simpler than the initial version. The steps before GC-MS are addition of deuterated internal standards in a single pipetting, addition of the reductant dithiothreitol and NaOH in a second pipetting, heating at 40#{176}C for 30 min, fractionation of sample on a disposable anion-exchange column, drying, and derivatization with N-methyl -N-(tertbutyldimethylsilyl)trifluoroacetamide.
The tert-butyldimethylsilyl derivatives are separated and quantified by capillary GC-MS in the selected-ion monitoring mode, with use of a benchtop GC-MS equipped with an autoeampler. The variable recovery through these steps and the reoxidation of Hey during sample processing are corrected for by including deuterated Hey as internal standard, which results in a highly precise assay. Using semiautomated pipetting equipment, a single technician can process 320 samples in 8 h. The capacity of the automated chromatograph is about 160 derivatized samples per 24 h. and N-methylglycine (65, 66) , and the fact that the assay has been verified for urine samples (12). With a slight modification, methylmalonic acid (60), 2-methylcitric acid (60), and betaine (66) in serum can also be determined.
Precolumn Derivatization, HPLC, and Fluorescence

Detection
In the method of Araki and Sako (11), Hey is derivatized with SBD-F, and the Hey, eysteine, and eysteinylglycine adducts are separated and quantified by gradient elution of a reversed-phase column within 12 mm. This method has been improved by Ubbink The baseline fluctuation in this method reflects differences in absorbance between reagent and mobile phase. Therefore, the baseline noise is minimized by cooling the reagent reservoir to avoid hydrolysis and by delivering the postcolumn reagent with low pulsation flow. Published methods for the determination of total Hey are listed in Table 2 , and the performance and practicalities of five methods are compared in Table 1 .
Correlation Studies
Sample Collection and Stability
Effect of FoodIntake
The data on possible diurnal variation in plasma Hey and its relation to normal food intake are sparse and inconsistent. Malinow et al. (13) Slight modifications are required for the codeterminatlon of these metabolifes (see references in the text). 1-2 h (44, 79) , and peak plasma Hey is usually measured after 4-8 h (20, 44, 79, 80) . Thus, both after a meal and after a peroral methionine load there is a time difference of about 3-4 h between the maximal plcIRmR concentrations for methionine and Hey.
These Plasma Hey is to a large extent bound to albumin (10). Because of postural hemodilution, serum albumin averages 9% more in the blood collected from subjects who are standing than from those in the supine position (84) . The position may, therefore, affect the measured plasma Hey values, but this has not been evaluated. The stability of total Hey in whole blood and plasma/ serum under various conditions is summarized in Table 3 .
Stability of Hcy in
Reference Values
The normal values for total Hey differ somewhat from one laboratory to another (Table 4) , but values between 5 and 15 mol/L are usually considered as normal. The variability may be related to different methodologies (Table 2), differences in sample processing, or the selection of subjects who are under the influence of various factors that affect the concentration of plasma/serum Hey. Total plasma Hey seems to be dependent on age, gender, and, in women, possibly menopausal status (77) . The large differences in cysteine-Hey disulfide concentrations between pre-and postmenopausal women reported earlier (6, (86) (87) (88) #{149} Mean ± 2 SD after log normalization to correctfor skewness towards higher values. The samples were allowed to stand at room temperature for [1] [2] [3] [4] h before centrifugatlon.
'Same as exceptthat samples were centrifuged wIthin 1 h of collection.
9Normotensive. "Hypertensive. 'PosfrnenopausaL 1Blacktilbe.
Total Hcy in Laboratory Diagnosis
Cobalamin Deficiency The classical view of cobalainin (vitamin B12) deficiency is that it usually develops at age >60 years; usually presents with megaloblastic anemia, macrocy-
7'
tosis, and hypersegmented neutrophils;
and is often accompanied by neurological abnormalities.
In these cases, the hematological picture was taken as an important diagnostic feature (91 Concentrations of total Hey in plasma/serum are increased in most patients with cobalamin deficiency (21,  25,28, 35, 93, 94, 99) . In a large population of patients, some of whom have classical cobalamin deficiency, se- of 25 mg (80) to 8 g/m2 (108, 109) 
